By Deena Beasley and Julie Steenhuysen SAN DIEGO, Dec 3 (Reuters) - Details from two large trials of Novo Nordisk's GLP-1 ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days.

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

A. Gastroparesis means stomach paralysis. The drug semaglutide (Ozempic, Rybelsus, Wegovy) can cause delayed stomach emptying ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days. Luckily, they are getting better, but I’m still ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.

Q. You wrote recently about the dangers of takingmelatonin for insomnia, especially in large doses.In the study you cited, more people taking this pill had heart failure.

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

Does Weight Loss Medication Work? Key takeaways Weight loss medications work for many people. They can help those with ...

By Stine Jacobsen, Maggie Fick and Jacob Gronholt-Pedersen COPENHAGEN (Reuters) -Novo Nordisk's closely watched Alzheimer's ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.